Basel, Switzerland

Jörg Brozio

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.0

ph-index = 6

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: A Spotlight on Jörg Brozio: Innovator from Basel

Introduction

Jörg Brozio is a notable inventor based in Basel, Switzerland, known for his contributions to the field of pharmaceuticals and innovative chemical compounds. With a total of seven patents to his name, Brozio has made significant strides in advancing drug formulation and development.

Latest Patents

Among his latest patents are the "Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide," which highlights the development of specialized salts. Additionally, he has patented "Crystalline forms of 4-methyl-N-3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide," which focuses on various crystalline forms of this compound and its preparation through distinct processes.

Career Highlights

Jörg Brozio has held positions at esteemed organizations such as Novartis AG and Novartis Pharma GmbH. His experience in these leading pharmaceutical companies has played a crucial role in shaping his expertise and innovations in drug development.

Collaborations

Throughout his career, Brozio has collaborated with esteemed colleagues, including Paul William Manley and Wen-Chung Shieh. These partnerships have enriched his inventions and expanded the scope of his research, contributing to the significant advancements in their field.

Conclusion

As a talented inventor, Jörg Brozio continues to drive innovation in pharmaceuticals with his patents and collaborative efforts. His work is a testament to the importance of creativity and research in the ongoing development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…